Social Cognition and Personality Changes in Alzheimer's & Parkinson's Disease & Frontotemporal Lobar Degeneration
Assessing Changes in Social Cognition and Personality in Patients with Frontotemporal Lobar Degeneration, Alzheimer's Disease and Parkinson's Disease and Their Effect on the Patient-caregiver Relationship
1 other identifier
observational
120
1 country
1
Brief Summary
The aim of this study is to compare personality and social cognition changes, including emotion detection and self-awareness, and neuroanatomical correlates in patients, and how that affects the caregiver-patient relationship.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Jan 2013
Typical duration for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 1, 2013
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 16, 2016
CompletedStudy Completion
Last participant's last visit for all outcomes
August 16, 2016
CompletedFirst Submitted
Initial submission to the registry
September 23, 2016
CompletedFirst Posted
Study publicly available on registry
November 16, 2016
CompletedDecember 18, 2024
April 1, 2019
3.6 years
September 23, 2016
December 13, 2024
Conditions
Outcome Measures
Primary Outcomes (14)
Personality via the Interpersonal Adjectives Scales and differences between AD, PD, and FTLD
Assesses interpersonal aspects of personality
one time visit, through study completion of 3 years
Personality via the Behaviour Inhibition/Approach Scale (BIS/BAS) and differences between AD, PD, and FTLD
Assesses the behavioural approach system that regulates appetitive motives, in which the goal is to move toward something desired, and the behavioural avoidance (or inhibition) system that regulates aversive motives, in which the goal is to move away from something unpleasant
one time visit, through study completion of 3 years
Personality via the Big Five Inventory (BFI) and differences between AD, PD, and FTLD
Assesses the patient's Big Five dimensions (openness, conscientiousness, extraversion, agreeableness, and neuroticism) with respect to past and current behavior
one time visit, through study completion of 3 years
Social cognition via Social Norms Questionnaire and differences between AD, PD, and FTLD
Assesses the patient's understanding of culturally relevant social norms
one time visit, through study completion of 3 years
Social cognition via Interpersonal Reactivity Index (IRI) and differences between AD, PD, and FTLD
Assesses the patient's empathy or ability to share in another's mental and emotional experience
one time visit, through study completion of 3 years
Social cognition via Revised Self-Monitoring Scale (RSMS) and differences between AD, PD, and FTLD
Assesses the patient's sensitivity to the expressive behaviour of others and their ability to monitor their self-presentation
one time visit, through study completion of 3 years
Social cognition via Social Behaviour Observer Checklist and differences between AD, PD, and FTLD
Assesses behaviors specific to behavioural variant Frontotemporal Dementia (bvFTD) and is helpful in differentiating bvFTD versus Alzheimer's disease.
one time visit, through study completion of 3 years
Neuropsychiatric Inventory (NPI) and differences between AD, PD, and FTLD
Assesses 12 neuropsychiatric disturbances commonly encountered in patients with dementia, including: delusions, hallucinations, agitation, dysphoria, anxiety, apathy, irritability, euphoria, disinhibition, aberrant motor behaviour, night-time behaviour disturbances, and appetite and eating abnormalities
one time visit, through study completion of 3 years
Clinical Dementia Rating Scale (CDR) and differences between AD, PD, and FTLD
Assesses 8 domains of global dementia, including: memory, orientation, judgment/problem solving, community affairs, home and hobbies, personal care, behavioural comportment and personality, and language
one time visit, through study completion of 3 years
Functional Activities Questionnaire (FAQ) and differences between AD, PD, and FTLD
Assesses functional capacity in older adults
one time visit, through study completion of 3 years
Behavioural Tests composite score and differences between AD, PD, and FTLD
Orientation, Digit span backward and forward, Naming, Modified trails, Benson figure copy, Cerad, Clock draw
one time visit, through study completion of 3 years
Emotion Evaluation Task (EET) portion of The Awareness of Social Inference Test and differences between AD, PD, and FTLD
Assesses the recognition of six basic emotions commonly recognized across cultures (happiness, sadness, anger, surprise, disgust, fear) as well as a seventh "neutral" emotion. The emotions are presented via video vignettes. After viewing each scene, the patient will be asked to choose the emotion represented from a list of seven emotional categories. The caregiver will complete the test separately, and be asked both to guess the emotion in each vignette, and to speculate on which emotion the patient will guess.
one time visit, through study completion of 3 years
Geriatric Depression Scale (GDS) and differences between AD, PD, and FTLD
Assesses mood and depression in geriatric patients
one time visit, through study completion of 3 years
Neuroimaging and differences between AD, PD, and FTLD
Functional connectivity of networks associated with social cognition and personality
one time visit, through study completion of 3 years
Study Arms (4)
Alzheimer's disease
Observational Study
Parkinson's disease
Observational Study
Frontotemporal Lobar Degeneration
Observational Study
Healthy Controls
Observational Study
Interventions
This is an observational study.
Eligibility Criteria
Patients with a diagnosis of Alzheimer's disease, Parkinson's disease or Frontotemporal Lobar Degeneration
You may qualify if:
- Patients:
- ability to speak and understand the English language (as questionnaires and tests are only available in English)
- Caregivers:
- primary caregiver for a given patient
- ability to speak and understand the English language (as questionnaires and tests are only available in English)
You may not qualify if:
- Patients and Caregivers:
- history of another neurological disorder
- psychiatric disorder
- severe aphasia (semantic word loss)
- visual deficits requiring correction beyond the use of eyeglasses or contact lenses (intact visual acuity is required for completing both the questionnaires and the emotion evaluation test which consists of video vignettes)
- auditory deficits requiring correction beyond hearing aids (videos have auditory component)
- Patients:
- presence of pacemakers, aneurysm clips, artificial heart valves, ear implants, metal fragments or foreign objects in the eyes, skin or body will be excluded as they will be unable to have a MRI scan.
- premenopausal women will be excluded due to the unknown risk of MRIs during pregnancy.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Toronto Western Hospital, University Health Network
Toronto, Ontario, M5T 2S8, Canada
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Maria C Tartaglia, M.D.
Toronto Western Hospital, UHN; Tanz CRND
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- CROSS SECTIONAL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal Investigator
Study Record Dates
First Submitted
September 23, 2016
First Posted
November 16, 2016
Study Start
January 1, 2013
Primary Completion
August 16, 2016
Study Completion
August 16, 2016
Last Updated
December 18, 2024
Record last verified: 2019-04
Data Sharing
- IPD Sharing
- Will not share